What Researchers Did
Researchers conducted a review to discuss the clinical utility and mechanisms of ozone therapy and hyperbaric oxygen therapy for degenerative disc disease.
What They Found
The review highlighted that disc herniation affects over 3 million cases annually. It detailed the mechanisms and potential medical, surgical, and gene-based therapeutic applications of ozone therapy, alongside the utility of hyperbaric oxygen therapy, in managing degenerative disc disease.
What This Means for Canadian Patients
Canadian patients suffering from degenerative disc disease may benefit from understanding these reviewed therapies as potential options for pain relief and healing. However, further research is needed to establish their widespread clinical application and availability within the Canadian healthcare system.
Canadian Relevance
This review has no direct Canadian connection as it does not involve Canadian researchers, patients, or healthcare settings.
Study Limitations
As a review article, this study synthesizes existing literature without presenting new primary research data or clinical trial outcomes.